Stay updated on Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.5.4 tag, representing a small software update to the ClinicalTrials.gov page. This change does not modify the study content or documents.
    Difference
    0.1%
    Check dated 2026-05-15T05:39:17.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    No Change Detected
  5. Check
    28 days ago
    Change Detected
    Summary
    The page’s release/version indicator was incremented from “v3.5.2” to “v3.5.3,” reflecting a minor site revision rather than a change to the study record.
    Difference
    0.1%
    Check dated 2026-04-24T06:14:19.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Site revision label updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:33:13.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The revision history is updated to include v3.5.0 as the latest revision and removes v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T04:48:50.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T00:29:09.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    The study status was updated to Completed with actual completion dates, replacing the previous 'Active, not recruiting' status. The page revision was updated to v3.4.2 and the funding-status notice was removed.
    Difference
    0.8%
    Check dated 2026-02-11T11:43:11.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial page.